Pegavision Corporation (TPE:6491)
Taiwan · Delayed Price · Currency is TWD 311.00
+3.00 (0.97%)
Nov 25, 2025, 1:30 PM CST
Pegavision Market Cap
Pegavision has a market cap or net worth of 24.02 billion as of November 24, 2025. Its market cap has decreased by -17.98% in one year.
Market Cap
24.02B
Enterprise Value
21.16B
Revenue
6.90B
Ranking
n/a
PE Ratio
15.11
Stock Price
311.00
Market Cap Chart
Since December 30, 2014, Pegavision's market cap has increased from 9.60B to 24.02B, an increase of 150.25%. That is a compound annual growth rate of 8.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 24.02B | -18.30% |
| Dec 31, 2024 | 29.41B | -4.92% |
| Dec 29, 2023 | 30.93B | 4.20% |
| Dec 30, 2022 | 29.68B | -0.70% |
| Dec 30, 2021 | 29.89B | 50.88% |
| Dec 31, 2020 | 19.81B | 55.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 213.25B |
| PharmaEssentia | 180.30B |
| Lotus Pharmaceutical | 77.05B |
| Bora Pharmaceuticals Co., LTD. | 66.43B |
| Lumosa Therapeutics | 31.84B |
| Oneness Biotech | 29.03B |
| Lin BioScience | 28.54B |
| Center Laboratories | 27.36B |